QR Code

Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA.

With the eventual goal of developing a treatment for chronic myelogenous leukemia (CML), attempts have been made to design hammerhead ribozymes that can specifically cleave BCR-ABL fusion mRNA. In the case of L6 BCR-ABL fusion mRNA (b2a2 type; BCR exon 2 is fused to ABL exon 2), which has no effecti...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nucleic Acids Res
Auteurs principaux: Kuwabara, T, Warashina, M, Tanabe, T, Tani, K, Asano, S, Taira, K
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 1997
Sujets:
Accès en ligne:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC146844/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9224607/
https://ncbi.nlm.nih.govhttps://doi.org/10.1093/nar/25.15.3074
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!